Evaxion Biotech EVAX is gearing up to announce its quarterly earnings on Tuesday, 2025-05-27. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Evaxion Biotech will report an earnings per share (EPS) of $-0.25.
The market awaits Evaxion Biotech’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Past Earnings Performance
In the previous earnings release, the company beat EPS by $0.08, leading to a 1.81% increase in the share price the following trading session.
Here’s a look at Evaxion Biotech’s past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -3.1 | -3.9 | -5.6 |
| EPS Actual | -0.07 | -0.4 | -1.2 | 0.3 |
| Price Change % | 2.0% | -3.0% | 10.0% | -6.0% |
Market Performance of Evaxion Biotech’s Stock
Shares of Evaxion Biotech were trading at $1.87 as of May 22. Over the last 52-week period, shares are down 90.18%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Evaxion Biotech visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
